Why the Prospa and G8 Education share prices both collapsed recently
We examine the earnings downgrades that contributed to the recent investor sell-off of G8 Education and Prospa stock.
Market musings
Yesterday we discussed how amongst all things: the market loves an earnings upgrade.
As we wrote, it was unsurprising that Appen's share price jumped as much as 14% after the company bumped up its full-year EBITDA guidance: from a shy $85m - $90m to $96m - $99m.
Of course, if the market loves an earnings upgrade, the other near-certainty is that the market absolutely hates an earnings downgrade.
Unsurprisingly then, when fresh-faced Prospa (ASX: PGL) and G8 Education (ASX: GEM) both announced earnings downgrades in the last week – the market was not shy about beating their share prices lower.
Below, we take a look at the details of both downgrades.
Practise trading Australian stocks with an IG demo account now
G8 share price: when assumptions fall away
In August the company remained mostly upbeat, noting the following:
'Balancing the performance of the organic centres with our caution in relation to the market environment, the forecast underlying EBIT range for CY19 is $140m - $145m.'
Had the company achieved such goals – or maybe more relevantly kept that estimate stable – it would have marked a slight increase on the company’s 2018 underlying EBIT of $136.3m. Not a big leap, but at the very least not a decline.
The above guidance however, as the company would later announce, was 'predicated upon occupancy growth of mid 1% pts and wage efficiencies.’
It looks as if G8 hasn’t quite hit those targets, with the company last week announcing that 'full-year underlying EBIT forecast is now expected to be $131-$134m for the year.’
Investors responded sharply and swiftly, with the G8 Education share price falling 24% since revealing this earnings downgrade to the market.
The G8 Education (ASX: GEM) share price currently trades at the $1.94 mark – well below its February high of $3.63 per share.
Prospa share price: earnings not so prosperous
Prospa Group Limited (ASX: PGL) listed on the ASX on June 11. The prospectus forecast 1H 2020 originations of $297.4m; revenues of $88.0m and EBITDA (pro forma) of $11.3m.
Good numbers, the market rated, as the Prospa share price ran as high as $5.090. Then, the music stopped. Or maybe more accurately: slowed.
Prospa yesterday revealed to the market that while 1H 2020 originations were actually set to come in a little higher than previously flagged: now at $298.2m; revenue and earnings both were expected to now come in significantly lower. Specifically, 1H 2020 revenue was now expected to come in at around $75.0m, while earnings (EBITDA) was expected even lower at just $4.0m.
The market punished this downgrade accordingly, bidding the stock down as much as 28.57% in the aftermath. PGL currently trades at $2.775 per share.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.
